Catheter Precision, Inc. (VTAK) - Form 8-K Summary
Business Context and Reporting Period
Catheter Precision, Inc., a Delaware corporation, filed this Current Report on Form 8-K on May 6, 2024. The filing announces the financial results for the quarter ended March 31, 2024. The company's common stock trades on the NYSE American under the symbol VTAK.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
No material changes versus the prior comparable period are described in the text of this filing. The document serves solely as a notification that the Q1 2024 results have been issued via a press release.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies within its main text. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be incorporated by reference into other SEC filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release Issued on May 6, 2024) for actual Q1 2024 financial figures.
- Verify the company's liquidity position and cash burn rate in the full press release.
- Check for any updated revenue guidance or operational milestones mentioned in the attached exhibit.
- Confirm the status of the Interim Chief Financial Officer, Margrit Thomassen, who signed the report.